Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 3
2007 3
2008 1
2009 1
2010 4
2011 8
2012 8
2013 4
2014 8
2015 4
2016 8
2017 12
2018 6
2019 6
2020 11
2021 27
2022 27
2023 25
2024 22
2025 24
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

187 results

Results by year

Filters applied: . Clear all
Page 1
[(177)Lu]Lu-DOTA-TATE plus long-acting octreotide versus high-dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2-3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study.
Singh S, Halperin D, Myrehaug S, Herrmann K, Pavel M, Kunz PL, Chasen B, Tafuto S, Lastoria S, Capdevila J, García-Burillo A, Oh DY, Yoo C, Halfdanarson TR, Falk S, Folitar I, Zhang Y, Aimone P, de Herder WW, Ferone D; all the NETTER-2 Trial Investigators. Singh S, et al. Lancet. 2024 Jun 29;403(10446):2807-2817. doi: 10.1016/S0140-6736(24)00701-3. Epub 2024 Jun 5. Lancet. 2024. PMID: 38851203 Clinical Trial.
Peptide receptor radionuclide therapy with [(177)Lu]Lu-DOTA-TATE.
Prado-Wohlwend S, Bernal-Vergara JC, Utrera-Costero A, Cañón-Sánchez JR, Agudelo-Cifuentes M, Bello-Arques P; Endocrinology Working Group of the SEMNIM. Prado-Wohlwend S, et al. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2022 Jan-Feb;41(1):55-65. doi: 10.1016/j.remnie.2021.11.001. Epub 2021 Dec 14. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2022. PMID: 34920969
Efficacy and Safety of [(177)Lu]Lu-DOTA-TATE in Adults with Inoperable or Metastatic Somatostatin Receptor-Positive Pheochromocytomas/Paragangliomas, Bronchial and Unknown Origin Neuroendocrine Tumors, and Medullary Thyroid Carcinoma: A Systematic Literature Review.
Hertelendi M, Belguenani O, Cherfi A, Folitar I, Kollar G, Polack BD. Hertelendi M, et al. Biomedicines. 2023 Mar 27;11(4):1024. doi: 10.3390/biomedicines11041024. Biomedicines. 2023. PMID: 37189646 Free PMC article. Review.
68Ga-autoclabeling of DOTA-TATE and DOTA-NOC.
Blom E, Koziorowski J. Blom E, et al. Appl Radiat Isot. 2012 Jun;70(6):980-3. doi: 10.1016/j.apradiso.2012.03.032. Epub 2012 Mar 28. Appl Radiat Isot. 2012. PMID: 22480913
187 results